Apellis Pharmaceuticals Inc Price to Earnings Ratio (PE) Ratios, (APLS) Valuation Ranking and Trends, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
• P/E Ratio TTM
• P/S Ratio TTM
• P/CF Ratio TTM
• P/FCF Ratio TTM
• Price to Book MRQ
• Price to Tangible Book

Apellis Pharmaceuticals Inc   (NASDAQ: APLS)
 



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

About APLS >> Compare APLS Price to Earnings Ratio to its Competitors >> Return to APLS Valuation Comparisons

APLS Price to Earnings Ratio Current (Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Diluted EPS 12 Trailing Months IV. Quarter III. Quarter II. Quarter I. Quarter
PE (TTM) Ratio current            39.45            156.41            75.23            75.23            75.23
Diluted EPS TTM Y / Y Change - % - % - % -34.06 % -48.56 %
Diluted EPS Y / Y Change - % 55.17 % - % 10 % 37.04 %
Stock performance to date 58.66 % 8.74 % 26.64 % -23.68 % -34.05 %

Price to earnings ratio Comment
Despite shareprice increase of 58.66 %, from beginning of I. Quarter Apellis Pharmaceuticals Inc 's current Price to earnings ratio has contracted due to eps growth of 0 %, to Pe of 39.45, from average Price to earnings ratio in IV. Quarter of 156.41.

Within Healthcare sector 175 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Apellis Pharmaceuticals Inc Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #70
Sector #176
S&P 500 #2053





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.